Cancer Incidence and Mortality for All Sites of Cancer, Monroe County, 2009-2013

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2163.6 564.1 10.9 2187.0 464.3 9.0 745.0 199.8 6.5 760.8 149.5 4.9
Oral cavity and pharynx
All Oral cavity and pharynx 63.6 15.9 1.8 38.8 7.8 1.1 11.8 3.0 0.8 8.8 1.6 0.5
Lip 2.6 0.7 0.4 2.4 0.5 0.3 0.4 0.1 0.1 0.0 0.0 0.0
Tongue 21.2 5.3 1.0 11.4 2.2 0.6 2.8 0.7 0.4 3.0 0.6 0.3
Salivary gland 5.6 1.4 0.5 4.4 0.9 0.4 0.8 0.2 0.2 1.6 0.3 0.2
Floor of mouth 4.0 1.0 0.5 1.8 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Gum & other mouth 7.2 1.8 0.6 10.4 2.1 0.6 1.2 0.3 0.3 1.4 0.2 0.2
Nasopharynx 1.0 0.3 0.2 0.4 0.1 0.1 0.8 0.2 0.2 0.4 0.1 0.1
Tonsil 13.4 3.3 0.8 4.6 1.0 0.4 1.4 0.3 0.2 0.4 0.1 0.1
Oropharynx 3.6 0.8 0.4 1.4 0.3 0.2 2.0 0.5 0.3 1.0 0.2 0.2
Hypopharynx 4.0 1.0 0.4 1.8 0.4 0.3 1.0 0.3 0.3 0.2 0.0 0.1
Other buccal cavity and pharynx 1.0 0.2 0.2 0.2 0.0 0.1 1.2 0.3 0.3 0.8 0.1 0.1
Digestive system
All Digestive system 381.2 98.5 4.5 326.2 66.1 3.3 203.2 53.2 3.3 173.8 33.1 2.3
Esophagus 34.2 8.7 1.3 10.4 1.9 0.5 35.6 9.3 1.4 8.4 1.6 0.5
Stomach 39.4 10.5 1.5 22.8 4.8 0.9 16.6 4.5 1.0 11.2 2.3 0.6
Small intestine 13.6 3.6 0.9 10.4 2.3 0.7 2.8 0.8 0.4 2.8 0.5 0.3
Colorectal 164.8 43.0 3.0 174.8 35.3 2.4 54.8 14.5 1.8 66.8 12.5 1.4
Colon excluding rectum 104.0 27.5 2.4 129.0 25.4 2.0 43.6 11.7 1.6 55.8 10.2 1.3
Cecum 23.2 6.3 1.2 32.2 6.2 1.0            
Appendix 6.4 1.6 0.6 4.8 1.0 0.4            
Ascending colon 16.0 4.2 0.9 29.8 5.7 0.9            
Hepatic flexure 4.8 1.3 0.5 5.4 1.1 0.4            
Transverse colon 10.4 2.8 0.8 11.0 2.1 0.6            
Splenic flexure 3.8 1.0 0.5 4.4 0.8 0.4            
Descending colon 5.8 1.5 0.6 5.8 1.2 0.5            
Sigmoid colon 27.0 7.0 1.2 27.8 5.8 1.0            
Large intestine, NOS 6.6 1.8 0.6 7.8 1.5 0.5            
Rectum & rectosigmoid 60.8 15.5 1.8 45.8 9.9 1.3 11.2 2.8 0.8 11.0 2.2 0.6
Rectosigmoid junction 13.8 3.6 0.9 13.6 2.9 0.7            
Rectum 47.0 11.9 1.6 32.2 7.1 1.1            
Anus, anal canal & anorectum 7.2 1.8 0.6 8.8 1.8 0.5 2.0 0.5 0.3 1.2 0.2 0.2
Liver and intrahepatic bile duct 44.0 10.8 1.5 17.6 3.7 0.8 32.4 8.3 1.3 19.4 3.8 0.8
Liver 39.2 9.6 1.4 13.0 2.7 0.7 23.8 5.9 1.1 10.0 2.0 0.6
Intrahepatic bile duct 4.8 1.3 0.5 4.6 1.0 0.4 8.6 2.3 0.7 9.4 1.8 0.5
Gallbladder 1.8 0.5 0.3 4.0 0.8 0.4 0.8 0.2 0.2 2.2 0.4 0.3
Other biliary 8.8 2.2 0.7 8.2 1.7 0.5 2.8 0.7 0.4 1.4 0.3 0.2
Pancreas 62.0 15.9 1.8 59.8 11.6 1.4 53.0 13.7 1.7 56.4 10.6 1.3
Retroperitoneum 2.8 0.7 0.4 2.6 0.7 0.4 0.2 0.1 0.1 0.4 0.1 0.1
Peritoneum, omentum & mesentery 0.4 0.1 0.1 4.4 0.9 0.4 0.4 0.1 0.1 1.0 0.2 0.2
Other digestive organs 2.2 0.6 0.3 2.4 0.5 0.3 1.8 0.4 0.3 2.6 0.5 0.3
Respiratory system
All Respiratory system 310.6 81.9 4.2 296.0 60.3 3.1 224.2 59.9 3.6 195.2 39.4 2.5
Nasal cavity, middle ear & sinuses 2.8 0.7 0.4 4.0 0.8 0.4 0.8 0.2 0.2 0.8 0.1 0.1
Larynx 23.8 6.2 1.1 5.2 1.0 0.4 9.2 2.4 0.7 3.4 0.7 0.3
Lung and bronchus 283.2 74.8 4.0 286.0 58.3 3.1 213.4 57.0 3.5 190.6 38.5 2.5
Pleura 0.4 0.1 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 0.4 0.1 0.2 0.8 0.2 0.2 0.4 0.1 0.2 0.4 0.1 0.1
Soft tissue, bone, and skin
Bones & joints 4.4 1.2 0.5 4.0 1.0 0.5 2.4 0.6 0.3 1.4 0.3 0.2
Soft tissue (including heart) 13.2 3.5 0.9 14.2 3.4 0.8 5.2 1.4 0.6 6.6 1.4 0.5
Skin~ 119.0 32.2 2.6 101.4 23.7 2.1 18.6 5.1 1.0 12.4 2.4 0.6
Melanoma of the skin 108.2 29.2 2.5 94.4 22.2 2.1 12.4 3.4 0.9 9.6 1.9 0.5
Breast
Breast 5.4 1.4 0.6 655.6 142.4 5.0 1.0 0.3 0.3 106.6 21.2 1.9
Female genital system
All Female genital system       259.0 54.4 3.0       90.6 18.0 1.7
Cervix uteri       26.6 6.3 1.1       9.4 2.1 0.6
Corpus uterus and NOS       148.6 30.6 2.2       31.2 6.0 1.0
Ovary       58.8 12.5 1.5       44.6 9.0 1.2
Vagina       1.6 0.3 0.2       0.8 0.2 0.2
Vulva       16.8 3.4 0.8       2.4 0.4 0.2
Other female genital organs       6.6 1.3 0.4       2.2 0.4 0.2
Male genital system
All Male genital system 619.8 156.0 5.6       66.2 18.5 2.0      
Prostate 595.0 148.8 5.5       64.6 18.1 2.0      
Testis 21.4 6.2 1.2       0.6 0.1 0.2      
Penis 2.8 0.8 0.4       0.8 0.2 0.2      
Other male genital organs 0.6 0.1 0.2       0.2 0.1 0.1      
Urinary system
All Urinary system 266.0 71.6 3.9 105.6 21.4 1.9 54.2 14.7 1.8 19.2 3.3 0.7
Urinary bladder (including in situ) 161.8 44.4 3.1 50.0 9.9 1.3 32.0 8.9 1.4 8.6 1.4 0.4
Kidney and renal pelvis 97.4 25.3 2.3 53.4 11.1 1.4 21.0 5.5 1.1 10.2 1.9 0.5
Ureter 2.2 0.6 0.4 0.8 0.2 0.2 0.6 0.2 0.2 0.0 0.0 0.0
Other urinary organs 4.6 1.3 0.5 1.4 0.3 0.2 0.6 0.2 0.2 0.4 0.1 0.1
Eye & orbit
Eye & orbit 2.0 0.5 0.3 1.8 0.4 0.2 0.0 0.0 0.0 0.4 0.1 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 56.0 14.7 1.8 90.4 19.9 1.9 20.8 5.6 1.1 20.6 4.4 0.9
Malignant brain / other nervous system 23.4 6.3 1.2 26.2 6.4 1.1 17.4 4.7 1.0 16.8 3.7 0.8
Malignant brain 21.8 5.8 1.1 23.8 5.7 1.1            
Malignant other nervous system 1.6 0.4 0.3 2.4 0.6 0.4            
Benign brain / other nervous system* 32.6 8.4 1.3 64.2 13.6 1.5 3.4 0.9 0.4 3.8 0.7 0.3
Benign brain 2.6 0.6 0.4 3.4 0.7 0.4            
Benign other nervous system 30.0 7.8 1.3 60.8 12.8 1.5            
Endocrine system
All Endocrine system 34.4 9.1 1.4 79.6 19.7 2.0 2.8 0.8 0.4 5.2 1.0 0.4
Thyroid 31.6 8.3 1.3 76.4 19.0 2.0 2.2 0.6 0.3 4.0 0.7 0.3
Other endocrine (including thymus) 2.8 0.7 0.4 3.2 0.8 0.4 0.6 0.2 0.2 1.2 0.3 0.2
Lymphomas
All Lymphomas 112.8 30.3 2.5 99.4 21.1 1.9 30.0 8.3 1.3 25.2 4.7 0.9
Hodgkin lymphoma 11.8 3.2 0.8 13.0 3.3 0.8 0.6 0.2 0.2 1.4 0.3 0.2
Non-Hodgkin lymphomas 101.0 27.0 2.4 86.4 17.8 1.7 29.4 8.1 1.3 23.8 4.4 0.8
Myeloma
All Myeloma 34.4 8.9 1.4 24.2 4.9 0.9 17.6 4.7 1.0 13.0 2.5 0.6
Leukemias
All Leukemias 79.4 21.4 2.1 65.0 13.9 1.6 38.4 10.6 1.5 32.2 6.4 1.0
Lymphocytic leukemias 42.8 11.2 1.5 31.6 6.7 1.1 11.4 3.0 0.8 9.0 1.7 0.5
Acute lymphocytic leukemia 3.6 1.0 0.5 3.4 0.9 0.4 1.8 0.5 0.4 1.8 0.4 0.3
Chronic lymphocytic leukemia 35.0 9.2 1.4 25.6 5.2 0.9 9.2 2.4 0.7 6.0 1.0 0.4
Other lymphocytic leukemias 4.2 1.0 0.5 2.6 0.5 0.3 0.4 0.1 0.1 1.2 0.2 0.2
Myeloid and monocytic leukemias 34.2 9.5 1.4 31.6 6.9 1.1 18.6 5.2 1.1 18.2 3.7 0.8
Acute myeloid leukemia 21.4 5.9 1.1 21.6 4.7 0.9 17.0 4.8 1.0 15.8 3.2 0.7
Acute monocytic leukemia 1.2 0.3 0.3 1.6 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.1
Chronic myeloid leukemia 10.4 2.8 0.8 7.6 1.6 0.5 1.0 0.3 0.3 1.2 0.2 0.2
Other myeloid/monocytic leukemias 1.2 0.4 0.3 0.8 0.2 0.2 0.6 0.2 0.2 1.0 0.2 0.2
Other leukemias 2.4 0.7 0.4 1.8 0.4 0.3 8.4 2.3 0.7 5.0 1.0 0.4
Other acute leukemias 1.2 0.3 0.3 0.8 0.2 0.2 5.0 1.4 0.6 2.0 0.4 0.3
Aleukemic, subacute, leukemia NOS 1.2 0.4 0.3 1.0 0.2 0.2 3.4 0.9 0.4 3.0 0.6 0.3
Mesothelioma
Mesothelioma 5.6 1.6 0.6 1.2 0.3 0.2            
Kaposi sarcoma
Kaposi sarcoma 2.6 0.6 0.4 0.2 0.0 0.0            
Myelodysplastic syndromes
Myelodysplastic syndromes 33.2 9.3 1.4 25.0 4.6 0.8            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 13.2 3.5 0.9 19.8 4.3 0.9            
Ill defined and unspecified sites
Ill defined and unspecified sites 39.4 10.4 1.5 43.8 8.2 1.1 52.0 14.1 1.7 53.4 10.4 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2015.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.